SCHEMBL10677325

SCHEMBL10677325

CNc1c(C(=O)N(C)c2ccccn2)c(=O)n(C)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ PGR P06401 1/20 0.49
▸ RAB9A P51151 6/20 0.48
▸ NPC1 O15118 6/20 0.48
▸ KDM4E B2RXH2 6/20 0.48
▸ ALDH1A1 P00352 6/20 0.48
▸ MAPT P10636 5/20 0.48
▸ LMNA P02545 3/20 0.48
▸ TP53 P04637 2/20 0.48
▸ USP2 O75604 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ NLRP3 Q96P20 1/20 0.47
▸ HPGD P15428 3/20 0.44
▸ XBP1 P17861 1/20 0.44
▸ PADI4 Q9UM07 1/20 0.43
▸ SRC P12931 4/20 0.42
▸ EGFR P00533 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10671481 0.85 MEN1 (0.68) MEN1KMT2APGRRAB9ANPC1
SCHEMBL10677667 0.82 KMT2A (0.71) MEN1KMT2APGRRAB9ANPC1
SCHEMBL5166077 0.76 HDAC4 (0.56) MEN1KMT2APGRKDM4EALDH1A1
SCHEMBL10676877 0.75 MEN1 (0.55) MEN1KMT2APGRRAB9ANPC1
SCHEMBL10675916 0.74 MEN1 (0.73) MEN1KMT2APGRRAB9ANPC1
SCHEMBL9274930 0.74 MEN1 (0.50) MEN1KMT2APGRRAB9ANPC1
SCHEMBL10675460 0.73 MEN1 (0.64) MEN1KMT2APGRRAB9ANPC1
SCHEMBL10673396 0.73 RAB9A (0.51) MEN1KMT2APGRRAB9ANPC1
SCHEMBL10673010 0.72 KDM4E (0.61) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL10674517 0.71 MEN1 (0.68) MEN1KMT2APGRRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4738971-A ENHANCED CELL-MEDIATED IMMUNITY; ANTIARTHRITIC AGENTS; NONTOXIC AKTIEBOLASET LEO (SE) 1988-04-19 — — US disclosed
US-4547511-A FOR ENHANCIN CELL-MEDIATED IMMUNITY AKTIEBOLAGET LEO (SE) 1985-10-15 — — US disclosed
EP-0059698-B1 HETEROCYCLIC CARBOXAMIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND METHODS OF TREATMENT THEREWITH AB LEO (SE) 1985-09-25 — — EP disclosed
EP-0059698-A1 Heterocyclic carboxamides, compositions containing such compounds, processes for their preparation and methods of treatment therewith AB LEO (SE) 1982-09-08 — — EP disclosed
Send feedback